Results 211 to 220 of about 73,182 (298)
Journal of Extracellular Vesicles, Volume 14, Issue 7, July 2025.ABSTRACT Bacterial extracellular vesicles are spherical, nanosized structures with lipid bilayer membranes and can suppress tumour growth in cancer models. However, the efficacy of some of these models is limited. One potential way to enhance their effects is by loading the bacterial vesicles with immunostimulatory molecules.
Jan Lötvall +5 more
wiley +1 more source
Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: The multicenter SWORD phase 2 trial. [PDF]
Nat CommunNi J +9 more
europepmc +1 more source
Granulocyte-macrophage colony-stimulating factor-related eosinophilia and Loeffler's endocarditis [letter] [PDF]
, 1992 K Donhuijsen +4 more
openalex +1 more source
The Interplay of Cross‐Organ Immune Regulation in Inflammation and Cancer
MedComm, Volume 6, Issue 7, July 2025.Organs interact dynamically through immune regulation, influencing systemic immune responses and disease progression. We review molecular and cellular mechanisms of cross‐organ immune regulation in inflammation and cancer, focusing on gut, liver, and brain interactions with other organs.
Jie Dou +6 more
wiley +1 more source
Endoplasmic Reticulum Stress in Cancer
MedComm, Volume 6, Issue 7, July 2025.Persistent ER stress in tumors activates UPR sensors (IRE1α, PERK, ATF6), driving cancer proliferation, metastasis, immune evasion, and drug resistance. This review explores UPR‐mediated signaling crosstalk, angiogenesis, and therapeutic targeting to develop safer anticancer strategies.
Ruixin Zhou +5 more
wiley +1 more source
Transforming Growth Factor‐β Pathway: Biological Functions and Therapeutic Targets
MedComm, Volume 6, Issue 7, July 2025.Natural compounds modulate the TGF‐β pathway, which acts as both a tumor suppressor and promoter during cancer progression. Agents such as ginsenosides, halofuginone, and EGCG influence cell proliferation, apoptosis, and angiogenesis. These bioactive molecules may complement standard therapies, highlighting the need for advanced formulations ...
Reham Hassan Mekky +9 more
wiley +1 more source
Small, Volume 21, Issue 26, July 3, 2025.This review explores the potential of antimicrobial peptides (AMPs) and nanotechnology for the treatment of gastrointestinal infections. It analyzes bacterial resistance mechanisms, the antimicrobial actions of AMPs, and advances in nanocarriers, such as lipid‐based, polymeric, metallic, and mesoporous silica systems, that enhance peptide protection ...
Christian Shleider Carnero Canales +10 more
wiley +1 more source
Erratum: Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial. [PDF]
Am J Respir Crit Care Med, 2022 europepmc +1 more source